Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Anagenics Limited ( (AU:AN1) ) has issued an update.
Anagenics Limited announced the cessation of 2,935,000 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could influence its market positioning, potentially affecting stakeholders’ interests.
More about Anagenics Limited
Anagenics Limited operates in the biotechnology industry, focusing on the development and commercialization of innovative products and services. The company is involved in creating solutions that cater to various market needs within the biotech sector.
Current Market Cap: A$3.69M
For detailed information about AN1 stock, go to TipRanks’ Stock Analysis page.